VERSES, From

VERSES AI: From AI Pioneer to Corporate Shell as Operations Cease

27.06.2026 - 16:07:54 | boerse-global.de

VERSES AI stops all AI R&D amid cash crisis of $68k; stock down 96% in 12 months. Leadership resigns including top scientist. Partnerships terminated.

VERSES AI Halts AI Research, Stock Plunges 96% in Year
VERSES - VERSES AI: From AI Pioneer to Corporate Shell as Operations Cease 27.06.2026 - Bild: ĂĽber boerse-global.de

The once-high-flying artificial intelligence outfit VERSES AI has effectively abolished its core identity. On June 18, 2026, the board declared an immediate halt to all AI research and development activities, leaving behind a company with no product, no scientific foundation, and a cash balance of roughly $68,000. The move did not come from nowhere — it caps a year-long descent that saw a 59% year-to-date stock decline and a staggering 96% plunge over the preceding twelve months.

At the centre of the implosion sits a $10 million convertible note, bearing 10% annual interest, that fell due on June 20 — two days after the R&D shutdown. The company’s total debt stood at nearly $2 million, against annual free cash flow deficits of about $27 million. With such thin liquidity, raising fresh capital or taking on new debt would have hammered existing shareholders, who had already suffered 26% dilution from new share issuances over the prior year. The stock at the NEO Exchange last traded at C$0.60, a far cry from its 52-week high of C$24.48.

The leadership exodus that accompanied the announcement was both swift and damning. President and COO James Hendrickson, along with CTO Hari Thiruvengada, resigned, citing disputes with the board over compensation practices — specifically, the non-payment of earned wages to employees. More damaging still was the departure of Chief Science Officer Karl Friston, the renowned neuroscientist whose theory of active inference formed the intellectual backbone of VERSES’ “Genius” platform. His exit stripped the company of its remaining scientific credibility.

Should investors sell immediately? Or is it worth buying VERSES AI?

Two partnerships that VERSES had trumpeted as milestones only months earlier were also dismantled. The licensing deal with Prodigii AI, signed in April 2026, was terminated. That agreement had included an upfront fee of $350,000 and quarterly minimum payments of $125,000 over ten years, targeting sectors such as finance, insurance, cybersecurity, manufacturing, energy and healthcare. Additionally, the relationship with an unnamed global investment house was ended.

The company’s deterioration had been visible for months. In January 2026, roughly half the workforce was let go, and several executives either left or agreed to defer their salaries temporarily. Co-founder Dan Mapes and CFO Kevin Wilson departed in February — leaving a skeletal operation. Later private placements aimed at shoring up liquidity proved insufficient to sustain the AI strategy.

VERSES’ most recent revenue figure stood at $1.8 million — a modest sum for a business that once pitched itself as a frontier AI player. The board now says it is exploring alternative business models and financing options, but acknowledges that no transaction may emerge that secures continued operations. CEO David T. Scott, who signed the notice, now holds the fate of a company that, for all practical purposes, no longer exists as the entity that went public.

Ad

VERSES AI Stock: New Analysis - 27 June

Fresh VERSES AI information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated VERSES AI analysis...

en | CA92539Q6040 | VERSES | boerse | 69641109 |